logo

Disease Markers

Disease Markers / Table of Contents

Table of Contents

Table of Contents

  • Disease Markers -
  • Special Issue
  • - Volume 2018
  • - Article ID 2380179
  • - Research Article

Serum Procalcitonin Levels in Acute Encephalopathy with Biphasic Seizures and Late Reduced Diffusion

Yosuke Fujii | Masato Yashiro | ... | Hirokazu Tsukahara
  • Disease Markers -
  • Special Issue
  • - Volume 2018
  • - Article ID 5285392
  • - Research Article

Apelin and Atrial Fibrillation: The Role in the Arrhythmia Recurrence Prognosis

Agata Salska | Michał Dziuba | ... | Marzenna Zielinska
  • Disease Markers -
  • Special Issue
  • - Volume 2018
  • - Article ID 6974191
  • - Research Article

Plasma Neuregulin 4 Levels Are Associated with Metabolic Syndrome in Patients Newly Diagnosed with Type 2 Diabetes Mellitus

Pijun Yan | Yong Xu | ... | Zhihong Zhang
  • Disease Markers -
  • Special Issue
  • Volume 2018
  • - Article ID 7308168
  • - Review Article

Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data

Henning Reis | Ulrich Krafft | ... | Tibor Szarvas
  • Disease Markers -
  • Special Issue
  • Volume 2018
  • - Article ID 9131432
  • - Research Article

Allergic Rhinitis and Its Relationship with IL-10, IL-17, TGF-β, IFN-γ, IL 22, and IL-35

P. Bayrak Degirmenci | S. Aksun | ... | C. Kırmaz
  • Disease Markers -
  • Special Issue
  • Volume 2018
  • - Article ID 5298057
  • - Research Article

Identification of Pathogenic Genes of Nonsyndromic Hearing Loss in Uyghur Families Using Massively Parallel DNA Sequencing Technique

Yu Chen | Yu Lu | ... | Huijun Yuan
  • Disease Markers -
  • Special Issue
  • - Volume 2018
  • - Article ID 8658507
  • - Research Article

Urinary Clusterin Is Upregulated in Nephropathia Epidemica

Ekaterina V. Martynova | Adelya N. Maksudova | ... | Svetlana F. Khaiboullina
  • Disease Markers -
  • Special Issue
  • Volume 2018
  • - Article ID 1959506
  • - Review Article

Markers of Oral Lichen Planus Malignant Transformation

Mircea Tampa | Constantin Caruntu | ... | Simona-Roxana Georgescu
  • Disease Markers -
  • Special Issue
  • Volume 2018
  • - Article ID 1497879
  • - Research Article

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas

Pawel Sadlecki | Dariusz Grzanka | Marek Grabiec
  • Disease Markers -
  • Special Issue
  • Volume 2018
  • - Article ID 9369358
  • - Research Article

Expression of Pentose Phosphate Pathway-Related Proteins in Breast Cancer

Junjeong Choi | Eun-Sol Kim | Ja Seung Koo
  • Disease Markers -
  • Special Issue
  • - Volume 2018
  • - Article ID 9128128
  • - Clinical Study

Evaluation of Mediators Associated with the Inflammatory Response in Prostate Cancer Patients Undergoing Radiotherapy

Nice Bedini | Alessandro Cicchetti | ... | Riccardo Valdagni
  • Disease Markers -
  • Special Issue
  • Volume 2018
  • - Article ID 1463940
  • - Research Article

Growth Differentiation Factor-15 as a Predictor of Idiopathic Membranous Nephropathy Progression: A Retrospective Study

Young Rok Ham | Chang Hun Song | ... | Kang Wook Lee
  • Disease Markers -
  • Special Issue
  • - Volume 2018
  • - Article ID 4987103
  • - Editorial

Epigenetic Biomarkers in Cancer

Yuen Yee Cheng | Hong Chuan Jin | ... | Michael Grusch
  • Disease Markers -
  • Special Issue
  • Volume 2018
  • - Article ID 9191832
  • - Research Article

The Association between Glomerular Filtration Rate Estimated Using Different Equations and Mortality in the Japanese Community-Based Population: The Yamagata (Takahata) Study

Asami Kabasawa | Tsuneo Konta | ... | Isao Kubota
  • Disease Markers -
  • Special Issue
  • - Volume 2018
  • - Article ID 9749457
  • - Research Article

Mitochondrial Genome Mutations Associated with Myocardial Infarction

Margarita A. Sazonova | Anastasia I. Ryzhkova | ... | Alexander N. Orekhov

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.